Kim Sung Hwan, Ha Kang Wook, Kim Yun Hee, Seol Pyong-Hwa, Kwak Ho-Jun, Park Seung-Wan, Ryu Byung-Ju
Department of Physical Medicine and Rehabilitation, Sahmyook Medical Center, Seoul, Korea.
Ann Rehabil Med. 2016 Jun;40(3):509-19. doi: 10.5535/arm.2016.40.3.509. Epub 2016 Jun 29.
To investigate the effect of radial extracorporeal shock wave therapy (rESWT) on hemiplegic shoulder pain (HSP) syndrome.
In this monocentric, randomized, patient-assessor blinded, placebo-controlled trial, patients with HSP were randomly divided into the rESWT (n=17) and control (n=17) groups. Treatment was administered four times a week for 2 weeks. The visual analogue scale (VAS) score and Constant-Murley score (CS) were assessed before and after treatment, and at 2 and 4 weeks. The Modified Ashworth Scale and Fugl-Meyer Assessment scores and range of motion of the shoulder were also assessed.
VAS scores improved post-intervention and at the 2-week and 4-week follow-up in the intervention group (p<0.05). Respective differences in VAS scores between baseline and post-intervention in the intervention and control groups were -1.69±1.90 and -0.45±0.79, respectively (p<0.05), between baseline and 2-week follow-up in the intervention and control groups were -1.60±1.74 and -0.34±0.70, respectively (p<0.05), and between baseline and 4-week follow-up in the intervention and control groups were -1.61±1.73 and -0.33±0.71, respectively (p<0.05). Baseline CS improved from 19.12±11.02 to 20.88±10.37 post-intervention and to 20.41±10.82 at the 2-week follow-up only in the intervention group (p<0.05).
rESWT consisting of eight sessions could be one of the effective and safe modalities for pain management in people with HSP. Further studies are needed to generalize and support these results in patients with HSP and a variety conditions, and to understand the mechanism of rESWT for treating HSP.
探讨桡侧体外冲击波疗法(rESWT)对偏瘫肩痛(HSP)综合征的影响。
在这项单中心、随机、患者与评估者双盲、安慰剂对照试验中,将HSP患者随机分为rESWT组(n = 17)和对照组(n = 17)。每周治疗4次,共2周。在治疗前、治疗后、治疗后2周和4周评估视觉模拟量表(VAS)评分和Constant-Murley评分(CS)。还评估了改良Ashworth量表、Fugl-Meyer评估评分以及肩部活动范围。
干预组在干预后以及2周和4周随访时VAS评分改善(p < 0.05)。干预组和对照组干预后与基线时VAS评分的差异分别为-1.69±1.90和-0.45±0.79(p < 0.05),干预组和对照组在基线与2周随访时分别为-1.60±1.74和-0.34±0.70(p < 0.05),干预组和对照组在基线与4周随访时分别为-1.61±1.73和-0.33±0.71(p < 0.05)。仅干预组基线CS从19.12±11.02改善至干预后20.88±10.37,并在2周随访时改善至20.41±10.82(p < 0.05)。
由八次治疗组成的rESWT可能是HSP患者疼痛管理的有效且安全的方法之一。需要进一步研究以推广并支持这些针对HSP患者及多种情况的结果,并了解rESWT治疗HSP的机制。